JCI Insight (Jul 2023)

Circulating cell-free methylated DNA reveals tissue-specific, cellular damage from radiation treatment

  • Megan E. McNamara,
  • Netanel Loyfer,
  • Amber J. Kiliti,
  • Marcel O. Schmidt,
  • Sapir Shabi-Porat,
  • Sidharth S. Jain,
  • Sarah Martinez Roth,
  • A. Patrick McDeed IV,
  • Nesreen Shahrour,
  • Elizabeth Ballew,
  • Yun-Tien Lin,
  • Heng-Hong Li,
  • Anne Deslattes Mays,
  • Sonali Rudra,
  • Anna T. Riegel,
  • Keith Unger,
  • Tommy Kaplan,
  • Anton Wellstein

Journal volume & issue
Vol. 8, no. 14

Abstract

Read online

Radiation therapy is an effective cancer treatment, although damage to healthy tissues is common. Here we analyzed cell-free, methylated DNA released from dying cells into the circulation to evaluate radiation-induced cellular damage in different tissues. To map the circulating DNA fragments to human and mouse tissues, we established sequencing-based, cell-type-specific reference DNA methylation atlases. We found that cell-type-specific DNA blocks were mostly hypomethylated and located within signature genes of cellular identity. Cell-free DNA fragments were captured from serum samples by hybridization to CpG-rich DNA panels and mapped to the DNA methylation atlases. In a mouse model, thoracic radiation-induced tissue damage was reflected by dose-dependent increases in lung endothelial and cardiomyocyte methylated DNA in serum. The analysis of serum samples from patients with breast cancer undergoing radiation treatment revealed distinct dose-dependent and tissue-specific epithelial and endothelial responses to radiation across multiple organs. Strikingly, patients treated for right-sided breast cancers also showed increased hepatocyte and liver endothelial DNA in the circulation, indicating the impact on liver tissues. Thus, changes in cell-free methylated DNA can uncover cell-type-specific effects of radiation and provide a readout of the biologically effective radiation dose received by healthy tissues.

Keywords